Table 7 Comparison of heart failure indicators before and after joining a primary care patient enrollment model, by region and group type
| Â | Measure | Overall | Major Urban Centres | Non-Major Urban Centres | Rural Centres | ||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Before | After | Before | After | Before | After | Before | After |
FHG ‡ | Echocardiogram - 1 year |  |  |  |  |  |  | ||
| Â | 40-64 | 53.0 | 54.8 | 54.4 | 56.9 | 51.7 | 51.5^ | 42.2 | 42.5 |
| Â | Male | 55.2 | 56.6 | 56.3 | 59.1 | 54.5 | 53.5 | 45.5 | 40.3 |
| Â | Female | 49.6 | 52.0 | 51.5 | 53.6 | 47.4 | 48.6 | 37.9 | 47.2 |
| Â | 65-74 | 47.2 | 50.1 | 48.3 | 52.2 | 46.8 | 46.0 | 38.8 | 42.3 |
| Â | Male | 48.8 | 52.8 | 50.5 | 55.3 | 47.4 | 48.2 | 37.0 | 43.4^ |
| Â | Female | 45.3 | 47.1 | 45.6 | 48.9 | 46.1 | 43.6 | 40.5 | 41.1 |
| Â | 75+ | 37.6 | 38.5 | 38.9 | 40.1 | 36.1 | 36.6 | 30.5 | 28.6 |
| Â | Male | 39.9 | 42.3 | 40.6 | 44.9 | 40.2 | 39.8 | 31.8 | 25.0 |
| Â | Female | 35.9 | 35.4 | 37.6 | 36.2 | 33.2 | 34.1 | 29.5 | 31.7 |
| Â | Overall | 45.0 | 45.6^ | 46.2 | 47.6 | 43.8 | 42.7 | 36.8 | 35.6 |
| Â | Male | 48.1 | 49.2 | 49.2 | 51.8 | 47.6 | 45.8 | 37.9 | 34.3 |
| Â | Female | 41.8 | 41.9^ | 43.1 | 43.2 | 40.0 | 39.6 | 35.8 | 37.0 |
| Â | ACE Inhibitor - 1 year | Â | Â | Â | Â | Â | Â | Â | Â |
| Â | 65-74 | 68.7 | 64.0* | 67.9 | 64.4 | 70.7 | 62.5*^ | 68.5 | 65.8 |
| Â | Male | 73.5 | 69.4* | 72.4 | 70.0 | 75.5 | 67.1* | 76.5 | 71.1^ |
| Â | Female | 63.1 | 58.1* | 62.6 | 58.2 | 65.0 | 57.2 | 60.7 | 60.3 |
| Â | 75 and older | 65.3 | 60.6* | 66.1 | 61.7* | 63.0 | 59.0 | 66.7 | 55.3 |
| Â | Male | 68.9 | 65.4* | 70.0 | 66.0* | 66.0 | 63.7 | 68.2 | 65.3 |
| Â | Female | 62.8 | 56.7* | 63.2 | 58.1* | 60.9 | 55.4 | 65.6 | 46.5* |
| Â | Overall | 66.8 | 61.8* | 66.9 | 62.6* | 66.3 | 60.2*^ | 67.5 | 59.0* |
| Â | Male | 71.1 | 66.9* | 71.2 | 67.6* | 70.7 | 65.0* | 72.2 | 67.5 |
| Â | Female | 62.9 | 57.1* | 63.0 | 58.1* | 62.4 | 55.9*^ | 63.6 | 51.2* |
FHN § | Echocardiogram - 1 year |  |  |  |  |  |  | ||
| Â | 40-64 | 13.0 | 50.8* | 49.2 | 59.6 | 42.4 | 40.2^ | 49.5 | 50.7 |
| Â | Male | 28.4 | 54.6* | 51.9 | 65.0 | 42.4 | 44.2 | 48.2 | 52.5 |
| Â | Female | 19.0 | 45.5* | 45.1 | 52.3 | 42.4 | 34.3 | 51.0 | 48.5 |
| Â | 65-74 | 14.8 | 51.4* | 54.9 | 49.1 | 43.0 | 50.0 | 47.2 | 55.0 |
| Â | Male | 28.5 | 54.1* | 51.3 | 48.3 | 50.0 | 53.3 | 50.8 | 60.0^ |
| Â | Female | 20.4 | 47.9* | 59.1 | 50.0 | 32.6 | 46.0 | 42.6 | 47.7 |
| Â | 75+ | 31.9 | 34.6 | 36.9 | 35.5 | 25.8 | 32.1 | 29.9 | 36.0 |
| Â | Male | 33.7 | 40.5 | 40.9 | 41.3 | 22.6 | 34.7 | 32.1 | 44.0 |
| Â | Female | 30.6 | 30.8 | 33.9 | 31.4 | 27.8 | 30.7 | 28.4 | 30.0 |
| Â | Overall | 41.6 | 42.4^ | 45.7 | 43.9 | 36.4 | 38.8 | 40.9 | 44.3 |
| Â | Male | 44.3 | 48.3 | 47.8 | 49.6 | 40.1 | 43.7 | 43.6 | 51.0 |
| Â | Female | 38.8 | 37.1^ | 43.5 | 38.7 | 32.3 | 34.8 | 38.2 | 37.7 |
| Â | ACE Inhibitor - 1 year | Â | Â | Â | Â | Â | Â | Â | Â |
| Â | 65-74 | 69.6 | 64.5 | 68.3 | 63.9 | 73.7 | 72.7^ | 67.0 | 56.9 |
| Â | Male | 71.9 | 66.5 | 69.7 | 70.0 | 75.0 | 76.7 | 71.2 | 53.8^ |
| Â | Female | 66.7 | 62.0 | 66.7 | 56.3 | 71.7 | 68.0 | 61.7 | 61.4 |
| Â | 75 and older | 69.4 | 62.8 | 71.5 | 63.4 | 71.2 | 63.6 | 64.2 | 61.1 |
| Â | Male | 74.8 | 69.7 | 76.3 | 69.4 | 81.1 | 66.7 | 66.1 | 72.5 |
| Â | Female | 65.5 | 58.2 | 67.8 | 59.2 | 64.6 | 62.0 | 63.0 | 52.5 |
| Â | Overall | 69.5 | 63.4 | 70.2 | 63.6 | 72.4 | 66.8^ | 65.4 | 59.7 |
| Â | Male | 73.3 | 68.4 | 73.4 | 69.6 | 77.7 | 71.2 | 68.7 | 64.7 |
| Â | Female | 65.9 | 59.2 | 67.4 | 58.5 | 67.2 | 63.6^ | 62.5 | 54.9 |